warts management with drugs dose
I'll look up warts management with drug dosages from the medical library right away.
Reading File
Now let me search the library for warts management with drug dosages in parallel:
Finding Sources
Finding Sources
Searching PubMed
warts treatment pharmacological
Good results. Now let me read all three relevant sections in parallel:
Reading File
Reading File
Reading File
Now let me get more detailed drug information from the dermatology textbook and search for immunotherapy/other agents:
Reading File
Finding Sources
Excellent - I got very rich content. Let me read one more section to get the immunotherapy drug doses:
Reading File
I now have comprehensive information. Let me compile the full answer:
Warts Management - Drug Doses & Treatment Options
Warts are caused by human papillomavirus (HPV). Management is guided by wart type (common, plantar, anogenital, flat), patient age/immune status, and prior treatment response. At least 3 months of sustained management is a reasonable therapeutic trial.
A. COMMON & PLANTAR WARTS
1. Destructive / Occlusive Therapy
| Treatment | Dose / Protocol |
|---|---|
| Cryotherapy (liquid nitrogen) | Freeze to produce a blister; 30-45 sec thaw time for common warts; 10-sec sustained freeze with spray gun; repeat every 2-3 weeks |
| Salicylic acid (OTC 10-26%) | Soak area in water 5-10 min, apply, cover with strip bandage for 24 h; repeat daily; debride with pumice stone between applications |
| Cantharone (0.7% cantharidin) | Apply to wart, allow to dry, cover with occlusive tape for 24 h; blister forms in 24-72 h; repeat every 2-3 weeks |
| Silver nitrate | Applied topically (limited evidence); caution - risk of silver impregnation into skin |
2. Immunologic / Immunotherapy
| Treatment | Dose / Protocol |
|---|---|
| Oral cimetidine | 25-40 mg/kg/day; used as adjunct; single-agent efficacy ~30% (comparable to placebo) |
| Topical sensitizers (DNCB, squaric acid dibutylester, diphencyprone) | Office: 2-5% in acetone, every 2 weeks; OR take-home: 0.2-0.5% daily; keep covered 24 h after application; 60-80% cure rate |
| Intralesional Candida antigen | 0.1 mL injected into 1-3 lesions; repeat every 3-4 weeks; up to 80% cure rate |
| Oral zinc | Benefit only in zinc-deficient patients; limited by GI upset |
3. Antiproliferative Therapy
| Treatment | Dose / Protocol |
|---|---|
| Intralesional bleomycin | 1 U/mL injected until wart blanches; small warts (<5 mm): 0.1 mL; larger warts: 0.2 mL; can use 0.1 U/mL with multipuncture technique; repeat every 3 weeks; typically 1-2 treatments needed; ~90% response rate |
| Topical 5-fluorouracil (5-FU) | Applied topically for recalcitrant or flat warts |
| Intralesional 5-FU | Used in refractory cases |
Note: Bleomycin is reserved for recalcitrant warts in adults. Raynaud's phenomenon is a contraindication (risk of digital vasospasm/necrosis).
4. Surgical / Laser Options (for refractory warts)
- Pulsed dye laser: fluence 12.5-15 J/cm2, spot size 7 mm, extend 2 mm beyond wart; every 2-4 weeks; 70-90% success in refractory warts
- CO2 laser: 56-81% efficacy; scarring risk
- Surgical excision, curettage: reserved for refractory cases
B. ANOGENITAL WARTS
Patient-Applied (Self-Administered)
| Drug | Dose & Schedule |
|---|---|
| Imiquimod 3.75% cream | Once daily at bedtime; wash off after 6-10 hours; up to 16 weeks |
| Imiquimod 5% cream | Once at bedtime 3 times/week; wash off after 6-10 hours; up to 16 weeks |
| Podofilox (podophyllotoxin) 0.5% solution or gel | Apply twice daily for 3 days, then 4 days off = 1 cycle; up to 4 cycles; max 0.5 mL/day; total wart area must not exceed 10 cm2 |
| Sinecatechins 15% ointment | Apply 3 times/day for up to 16 weeks; do NOT wash off after application |
Provider-Administered
| Treatment | Dose / Protocol |
|---|---|
| Cryotherapy (liquid nitrogen/cryoprobe) | Repeat every 1-2 weeks |
| Trichloroacetic acid (TCA) or bichloroacetic acid (BCA) 80-90% | Apply to wart, allow to dry before patient stands; if intense pain, neutralize with soap/water or sodium bicarbonate; repeat weekly |
| Surgical excision, electrocautery, curettage | Performed with local anesthesia |
C. SPECIAL NOTES
- Pregnancy-safe options: Cryotherapy, TCA/BCA, surgical excision. Podofilox and sinecatechins are contraindicated in pregnancy. Imiquimod has limited data (animal data suggests low risk).
- Imiquimod side effects: erythema, irritation, ulceration, hypopigmentation; weakens latex condoms/diaphragms.
- Sinecatechins should be avoided in immunocompromised patients.
- Topical immunotherapy (DNCB, squaric acid, diphencyprone, Candida antigen) achieves 60-80% cure rates - comparable to destructive methods but less scar risk.
D. HPV VACCINATION (Prevention)
- Dosage: 0.5 mL IM
- Age <15 years: 2-dose schedule (0 and 6-12 months)
- Age ≥15 years: 3-dose schedule (0, 1-2 months, and 6 months)
- Immunocompromised (age 9-26): 3-dose schedule always
Sources:
- Andrews' Diseases of the Skin - Clinical Dermatology
- Campbell-Walsh-Wein Urology
- Goldman-Cecil Medicine
Recent evidence note: A 2025 meta-analysis (PMID: 40873359) evaluated ionic contra-viral therapy (digoxin-furosemide) for multiple cutaneous warts - an emerging approach not yet in standard guidelines.
This is a shared conversation. Sign in to Orris to start your own chat.